$195.03
+7.14 (+3.80%)
At Close: Jun 03, 2026
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:01pm, Wednesday, 17'th Sep 2025
In the latest trading session, DaVita HealthCare (DVA) closed at $128, marking a -1.62% move from the previous day.
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
10:46am, Wednesday, 17'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DaVita HealthCare (DVA) Stock Drops Despite Market Gains: Important Facts to Note
07:01pm, Wednesday, 10'th Sep 2025
DaVita HealthCare (DVA) closed at $132.26 in the latest trading session, marking a -3.26% move from the prior day.
Should Value Investors Buy DaVita (DVA) Stock?
05:31pm, Tuesday, 02'nd Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care
08:00am, Wednesday, 27'th Aug 2025
Largest kidney care research arm advances science to inform care delivery DENVER , Aug. 27, 2025 /PRNewswire/ -- As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensiv
Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows
05:59pm, Thursday, 21'st Aug 2025
A ransomware attack that encrypted certain elements of dialysis firm DaVita's network affected 2.7 million people, the U.S. health department's website showed on Thursday.
DaVita: Aggressive Buybacks Despite Rising Cost Of Debt
09:36am, Wednesday, 20'th Aug 2025
DaVita has reduced the share count by over 10% in the last six months, but interest expenses increased by 50% Y/Y. International revenues grew by 36% Y/Y, and DaVita is pending regulatory approval to
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
06:10am, Friday, 15'th Aug 2025
Warren Buffett is one of the most celebrated investors of our time. The famed chief executive officer of Berkshire Hathaway, who will celebrate his 95th birthday on Aug. 30, is finally retiring from t
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
10:41am, Tuesday, 12'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Investors Undervaluing DaVita (DVA) Right Now?
10:41am, Monday, 11'th Aug 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
07:00am, Thursday, 07'th Aug 2025
Continued Vafseo® (vadadustat) growth with Q2 2025 net product revenues increasing to $13.3 million ; Total Q2 2025 net product revenues increased to $60.5 million DaVita physicians are expected to b
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands
01:50pm, Wednesday, 06'th Aug 2025
DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.
DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript
10:02pm, Tuesday, 05'th Aug 2025
DaVita Inc. (NYSE:DVA ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Javier J. Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Nic Eliason - Gro
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
06:16pm, Tuesday, 05'th Aug 2025
DaVita HealthCare (DVA) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.7 per share. This compares to earnings of $2.59 per share a year ago.
DaVita beats quarterly profit on steady demand for dialysis services
05:15pm, Tuesday, 05'th Aug 2025
DaVita beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services.
Sign In
Buy DVA